Novonesis Toekomstige groei
Future criteriumcontroles 3/6
Novonesis zal naar verwachting groeien in winst en omzet met respectievelijk 30.7% en 10.1% per jaar. De winst per aandeel zal naar verwachting groeien met 21.7% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.1% zijn.
Belangrijke informatie
30.7%
Groei van de winst
21.7%
Groei van de winst per aandeel
Chemicals winstgroei | 21.8% |
Inkomstengroei | 10.1% |
Toekomstig rendement op eigen vermogen | 8.1% |
Dekking van analisten | Good |
Laatst bijgewerkt | 23 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well
Sep 27An Intrinsic Calculation For Novozymes A/S (CPH:NZYM B) Suggests It's 22% Undervalued
Sep 05Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?
Jun 24Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)
May 02Novozymes (CPH:NZYM B) Might Be Having Difficulty Using Its Capital Effectively
Apr 07Does Novozymes (CPH:NZYM B) Have A Healthy Balance Sheet?
Mar 26Is Now The Time To Put Novozymes (CPH:NZYM B) On Your Watchlist?
Mar 12Novozymes' (CPH:NZYM B) Profits Appear To Have Quality Issues
Feb 04Calculating The Fair Value Of Novozymes A/S (CPH:NZYM B)
Jan 29Is Novozymes (CPH:NZYM B) Using Too Much Debt?
Dec 23Returns On Capital At Novozymes (CPH:NZYM B) Paint A Concerning Picture
Dec 05A Look At The Intrinsic Value Of Novozymes A/S (CPH:NZYM B)
Oct 14These 4 Measures Indicate That Novozymes (CPH:NZYM B) Is Using Debt Reasonably Well
Sep 13The Returns On Capital At Novozymes (CPH:NZYM B) Don't Inspire Confidence
Aug 29Estimating The Fair Value Of Novozymes A/S (CPH:NZYM B)
Jul 13Here's Why Novozymes (CPH:NZYM B) Can Manage Its Debt Responsibly
Jun 13Here's What's Concerning About Novozymes' (CPH:NZYM B) Returns On Capital
May 29Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 4,529 | 827 | 874 | 1,332 | 13 |
12/31/2025 | 4,230 | 701 | 781 | 1,239 | 14 |
12/31/2024 | 3,946 | 312 | 627 | 1,036 | 14 |
6/30/2024 | 3,045 | 283 | 598 | 891 | N/A |
3/31/2024 | 2,696 | 332 | 486 | 779 | N/A |
12/31/2023 | 2,401 | 406 | 281 | 557 | N/A |
9/30/2023 | 2,390 | 430 | 169 | 485 | N/A |
6/30/2023 | 2,382 | 460 | 83 | 436 | N/A |
3/31/2023 | 2,390 | 487 | 83 | 476 | N/A |
12/31/2022 | 2,360 | 494 | 150 | 539 | N/A |
9/30/2022 | 2,268 | 460 | 206 | 554 | N/A |
6/30/2022 | 2,186 | 418 | 262 | 539 | N/A |
3/31/2022 | 2,090 | 416 | 337 | 530 | N/A |
12/31/2021 | 2,009 | 423 | 379 | 546 | N/A |
9/30/2021 | 1,958 | 427 | 461 | 593 | N/A |
6/30/2021 | 1,914 | 409 | 432 | 564 | N/A |
3/31/2021 | 1,883 | 389 | 443 | 577 | N/A |
12/31/2020 | 1,883 | 380 | 459 | 585 | N/A |
9/30/2020 | 1,920 | 415 | 442 | 521 | N/A |
6/30/2020 | 1,955 | 405 | 465 | 536 | N/A |
3/31/2020 | 1,968 | 439 | 407 | 482 | N/A |
12/31/2019 | 1,924 | 422 | 352 | 428 | N/A |
9/30/2019 | 1,923 | 411 | 316 | 460 | N/A |
6/30/2019 | 1,917 | 434 | 350 | 505 | N/A |
3/31/2019 | 1,922 | 417 | 309 | 477 | N/A |
12/31/2018 | 1,927 | 432 | 306 | 493 | N/A |
9/30/2018 | 1,924 | 427 | 303 | 515 | N/A |
6/30/2018 | 1,915 | 429 | 262 | 490 | N/A |
3/31/2018 | 1,920 | 423 | N/A | 501 | N/A |
12/31/2017 | 1,952 | 419 | N/A | 546 | N/A |
9/30/2017 | 1,958 | 421 | N/A | 533 | N/A |
6/30/2017 | 1,934 | 412 | N/A | 522 | N/A |
3/31/2017 | 1,919 | 414 | N/A | 547 | N/A |
12/31/2016 | 1,902 | 410 | N/A | 517 | N/A |
9/30/2016 | 1,864 | 394 | N/A | 488 | N/A |
6/30/2016 | 1,883 | 394 | N/A | 437 | N/A |
3/31/2016 | 1,883 | 384 | N/A | 450 | N/A |
12/31/2015 | 1,876 | 378 | N/A | 447 | N/A |
9/30/2015 | 1,840 | 366 | N/A | 395 | N/A |
6/30/2015 | 1,795 | 353 | N/A | 443 | N/A |
3/31/2015 | 1,741 | 340 | N/A | 454 | N/A |
12/31/2014 | 1,673 | 339 | N/A | 608 | N/A |
9/30/2014 | 1,641 | 334 | N/A | 680 | N/A |
6/30/2014 | 1,605 | 324 | N/A | 643 | N/A |
3/31/2014 | 1,598 | 319 | N/A | 567 | N/A |
12/31/2013 | 1,575 | 295 | N/A | 348 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei NSIS B ( 30.7% per jaar) ligt boven de spaarquote ( 1.2% ).
Winst versus markt: De winst van NSIS B ( 30.7% per jaar) zal naar verwachting sneller groeien dan de Danish markt ( 11.9% per jaar).
Hoge groeiwinsten: De winst van NSIS B zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van NSIS B ( 10.1% per jaar) zal naar verwachting langzamer groeien dan de markt Danish ( 10.1% per jaar).
Hoge groei-inkomsten: De omzet van NSIS B ( 10.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen NSIS B zal naar verwachting over 3 jaar laag zijn ( 8.1 %).